Table 1: Clinical data comparison for 2 groups of patients.
Prevention Group | Control Group | |
Case Number | 21 | 22 |
Male | 8 | 9 |
Female | 13 | 13 |
Age(year) | 45.9 | 47.3 |
Tumor Type | ||
Non-Hodgkin's lymphoma | 6 | 6 |
Breast Cancer | 4 | 4 |
Non-small cell lung cancer | 4 | 5 |
Small cell lung cancer | 2 | 1 |
Colorectal cancer | 2 | 3 |
Stomach cancer | 2 | 2 |
Ovarian cancer | 1 | 1 |
Tumor Stage | ||
II | 8 | 8 |
III | 7 | 8 |
IV | 6 | 6 |
Before chemotherapy | ||
HBeAg (+) | 12 | 14 |
HBeAg (-) | 9 | 8 |
ALT (U/L) | 30.49 ± 8.62 | 31.25 ± 9.14 |
TSB (µmol/L) | 16.51 ± 4.68 | 15.03 ± 5.17 |
HBV-DNA (+) | 71.4% (15/21) | 72.7% (16/22) |
Serum HBV-DNA levels (after a Log conversion) | 3.47 ± 1.82 | 3.39 ± 1.73 |